KEYTRUDA® (pembrolizumab) - Official Site
KEYTRUDA is a prescription medicine used to treat a kind of lung cancer called non–small cell lung cancer (NSCLC). KEYTRUDA may be used with the chemotherapy medicines pemetrexed and a platinum as your first treatment when your lung cancer has spread (advanced NSCLC) is a type called “nonsquamous”.
KEYTRUDA is a prescription medicine used to treat a kind of bladder and urinary tract cancer called urothelial cancer. KEYTRUDA may be used with the medicine enfortumab vedotin in adults when your bladder or urinary tract cancer has spread or cannot be removed by surgery (advanced urothelial cancer).
FAQs About KEYTRUDA® (pembrolizumab)
Find answers to frequently asked questions about KEYTRUDA® (pembrolizumab) including how does KEYTRUDA work, PD-L1 testing information, and more.
Use this guide to help you and your care team discuss the role of treatment before and after surgery for high-risk early-stage triple-negative breast cancer (TNBC)—and learn if a treatment plan that includes KEYTRUDA may be right for you. Table of contents.
Triple-Negative Breast Cancer (TNBC) - KEYTRUDA
It explains what KEYTRUDA is and how it works, contains questions to ask your care team before and after surgery, and has additional information to help you navigate your treatment plan including KEYTRUDA for high-risk early-stage TNBC.
Side Effects of KEYTRUDA® (pembrolizumab)
Common side effects of KEYTRUDA when used alone include: feeling tired, pain, including pain in muscles, rash, diarrhea, fever, cough, decreased appetite, itching, shortness of breath, constipation, bones or joints and stomach-area (abdominal) pain, nausea, and low levels of thyroid hormone.
COST INFO & FINANCIAL HELP - KEYTRUDA
Need more information about whether your insurance provider covers KEYTRUDA or about potential financial assistance options? If you need further information or help paying for KEYTRUDA (with or without insurance coverage), Merck may be able to help.
Advanced Cervical Cancer - KEYTRUDA® (pembrolizumab) - Patients
KEYTRUDA is a prescription medicine used to treat a kind of cancer called cervical cancer. KEYTRUDA may be used with chemotherapy and radiation therapy when your cervical cancer has spread to nearby tissue or organs or has affected your kidneys (Stage III to IVA cervical cancer based on FIGO 2014 classification).
Infusion Information and Resources for KEYTRUDA® …
View tips that may help while receiving KEYTRUDA® (pembrolizumab) including what to expect with your first infusion appointment and what to know about your treatment schedule.
Clinical Trial Results for Advanced Melanoma - KEYTRUDA
In advanced melanoma, KEYTRUDA reduced the risk of cancer spreading, growing, or getting worse by 42% compared to ipilimumab. Half of the people who received KEYTRUDA every 3 weeks were alive without disease progression at 4.1 months, compared to 2.8 months for people who received ipilimumab.